Tamuzimod (VTX002) is an orally active sphingosine-1-phosphate receptor 1 (S1PR1) modulator. By binding to and modulating S1PR1 expressed on the surface of activated lymphocytes, Tamuzimod mediates lymphocyte egress from lymphoid organs, thereby retaining lymphocytes in peripheral lymphoid tissues and reducing circulating lymphocyte counts. Tamuzimod can be used in research related to moderate-to-severe ulcerative colitis[1][2].
Molekulargewicht:
546.71
CAS Nummer:
[2097854-81-2]
Formel:
C21H13Cl3F3N5O3
Target-Kategorie:
LPL Receptor
Anwendungsbeschreibung:
MCE Product type: Reference compound1
* Mehrwertsteuer und Versandkosten nicht enthalten. Irrtümer und Preisänderungen vorbehalten
